January 2019—Genomic Testing Cooperative announced it will offer multiple laboratory-developed genomic profiling tests for hematologic and solid tumors using next-generation sequencing technology. The co-op provides a platform for cooperation between commercial, hospital-based, and academic laboratories. This co-op structure allows member laboratories to share resources and to participate in technological innovation and determine the type of tests being developed. In addition, the co-op provides economies of scale that reduce costs of innovation in NGS. Eight cancer genomic profiling tests are available.
Genomic Testing Cooperative, 949-540-9421